• A broadly-neutralizing antibody against <em>Ebolavirus</em> glycoprotein that potentiates the breadth and neutralization potency of other antibodies
• A mathematical model of Marburg virus disease outbreaks and the potential role of vaccination in control
• A nonlinear fractional epidemic model for the Marburg virus transmission with public health education
• A novel MARV glycoprotein-specific antibody with potentials of broad-spectrum neutralization to filovirus
• A tale of endurance: bats, viruses and immune dynamics
• AAV-vectored expression of Marburg virus-neutralizing antibody MR191 provides complete protection from challenge in a guinea pig model
• ACE2 acts as a novel regulator of TMPRSS2-catalyzed proteolytic activation of influenza A virus in airway cells
• Adeno-associated virus type 5 infection via PDGFRα is associated with Interstitial lung disease in systemic sclerosis and generates composite peptides and epitopes recognized by the agonistic immunoglobulins present in patients with systemic sclerosis
• Advancements in Marburg (MARV) Virus Vaccine Research With Its Recent Reemergence in Equatorial Guinea and Tanzania: A Scoping Review
• Alveolar macrophage-expressed Plet1 is a driver of lung epithelial repair after viral pneumonia
• An updated review on pathogenic coronaviruses (CoVs) amid the emergence of SARS-CoV-2 variants: A look into the repercussions and possible solutions
• Annual (2023) taxonomic update of RNA-directed RNA polymerase-encoding negative-sense RNA viruses (realm <em>Riboviria</em>: kingdom <em>Orthornavirae</em>: phylum <em>Negarnaviricota</em>)
• Antibody responses to rVSV-ZEBOV vaccination for Ebola virus disease across doses and continents: five-year durability
• Application of multiplex realtime PCR detection for hemorrhagic fever syndrome viruses
• Aptamer and aptasensor technology for diagnosis of infectious diseases: A mini review
• Bat-Borne Pathogens and Public Health in Rural African Artisanal Gold Mines
• Bioinformatic, Biochemical, and Immunological Mining of MHC Class I Restricted T Cell Epitopes for a Marburg Nucleoprotein Microparticle Vaccine
• Biological Weapon Toxicity
• Can Marburg virus be sexually transmitted?
• Case Series of Patients with Marburg Virus Disease, Equatorial Guinea, 2023
• Characteristics and outcomes of patients hospitalized for infection with influenza, SARS-CoV-2 or respiratory syncytial virus in the season 2022/2023 in a large German primary care centre
• Characterization of the Cynomolgus Macaque Model of Marburg Virus Disease and Assessment of Timing for Therapeutic Treatment Testing
• Contrasting effects of filamin A and B proteins in modulating filovirus entry
• Coordinated inflammatory responses dictate Marburg virus control by reservoir bats
• Design and characterization of protective pan-ebolavirus and pan-filovirus bispecific antibodies
• Design and development of new inhibitors against breast cancer, Monkeypox and Marburg virus by modification of natural Fisetin via in silico and SAR studies
• Design of a novel multi-epitope vaccine against Marburg virus using immunoinformatics studies
• Designing a novel and combinatorial multi-antigenic epitope-based vaccine "MarVax" against Marburg virus-a reverse vaccinology and immunoinformatics approach
• Development and validation of a French questionnaire that assesses knowledge, attitude, and practices toward Marburg diseases in sub-Saharan African countries
• Development of a non-infectious control for viral hemorrhagic fever PCR assays
• Development of an explainable AI system using routine clinical parameters for rapid differentiation of inflammatory conditions
• Development of an Immunochromatography Assay to Detect Marburg Virus and Ravn Virus
• Diagnostic and therapeutic delays in lung cancer during the COVID-19 pandemic: a single center experience at a German Cancer center
• Direct endothelial ENaC activation mitigates vasculopathy induced by SARS-CoV2 spike protein
• Divergent antibody recognition profiles are generated by protective mRNA vaccines against Marburg and Ravn viruses
• Ebola and Marburg virus disease
• Emergence of Marburg virus: a global perspective on fatal outbreaks and clinical challenges
• Exploration of phytochemical compounds against Marburg virus using QSAR, molecular dynamics, and free energy landscape
• Factors associated with depressive mood at the onset of multiple sclerosis - an analysis of 781 patients of the German NationMS cohort
• FASTMAP-a flexible and scalable immunopeptidomics pipeline for HLA- and antigen-specific T-cell epitope mapping based on artificial antigen-presenting cells
• Filoviruses: Scientific Gaps and Prototype Pathogen Recommendation
• First-ever Marburg virus disease outbreak in Equatorial Guinea and Tanzania: An imminent crisis in West and East Africa
• Functional characterization of AF-04, an afucosylated anti-MARV GP antibody
• Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease
• Hexestrol, an estrogen receptor agonist, inhibits Lassa virus entry
• Identification of CCZ1 as an essential lysosomal trafficking regulator in Marburg and Ebola virus infections
• Identification of novel inhibitors against VP40 protein of Marburg virus by integrating molecular modeling and dynamics approaches
• Impaired systemic nucleocapsid antigen clearance in severe COVID-19
• In silico CD4 + T-cell multiepitope prediction and HLA distribution analysis for Marburg Virus-A strategy for vaccine designing
• In silico exploration of deep-sea fungal metabolites as inhibitor of Ebola and Marburg VP35 and VP40
• Infection prevention and control of highly infectious pathogens in resource-limited countries: an experience from Marburg viral disease outbreak in Kagera Region - Tanzania
• Infection prevention and control: Qualitative study of the preparedness and response of Christian health Association of Ghana to Marburg virus disease in Ghana
• Isolation of Primary Porcine Bronchial Epithelial Cells for Nipah Virus Infections
• Macaque antibodies targeting Marburg virus glycoprotein induced by multivalent immunization
• Marburg virus disease in travellers
• Marburg virus disease outbreak in Tanzania: current efforts and recommendations - a short communication
• Marburg virus disease outbreaks, mathematical models, and disease parameters: a systematic review
• Marburg Virus Outbreak in Equatorial Guinea: Need for Speed
• Markers of antroponotic viral infections in vervet monkeys arrived from their natural habitat (Tanzania)
• Micro‒Global Positioning Systems for Identifying Nightly Opportunities for Marburg Virus Spillover to Humans by Egyptian Rousette Bats
• Modelling Marburg Virus Disease in Syrian Golden Hamsters: Contrasted Virulence between Angola and Ci67 strains
• Myeloid-derived suppressor cells in influenza virus-induced asthma exacerbation
• Novel antiviral approaches for Marburg: a promising therapeutics in the pipeline
• Novel proteolytic activation of Ebolavirus glycoprotein GP by TMPRSS2 and cathepsin L at an uncharted position can compensate for furin cleavage
• Oral administration of obeldesivir protects nonhuman primates against <em>Sudan ebolavirus</em>
• Peripheral immune responses to filoviruses in a reservoir versus spillover hosts reveal transcriptional correlates of disease
• Phosphatidylserine-exposing extracellular vesicles in body fluids are an innate defence against apoptotic mimicry viral pathogens
• Potent immunogenicity and protective efficacy of a multi-pathogen vaccination targeting Ebola, Sudan, Marburg and Lassa viruse
• Preparing for future outbreaks in Ghana: An overview of current COVID-19, monkeypox, and Marburg disease outbreaks
• Preservation of scRNA-Seq Libraries Using Existing Inactivation Protocols
• Prevalence of human filovirus infections in sub-Saharan Africa: A systematic review and meta-analysis protocol
• Production and Purification of Filovirus Glycoproteins
• Quantitative assay to analyze neutralization and inhibition of authentic Middle East respiratory syndrome coronavirus
• Rescue and characterization of the first West African Marburg virus 2021 from Guinea
• Respiratory viral infections : Under special consideration of severe acute respiratory syndrome coronavirus 2 and influenza viruses
• Reverse Genetics Systems for Filoviruses
• Rise of Marburg virus in Africa: a call for global preparedness
• RSV vaccination strategies for high-risk patients 2023: a collaborative position paper by leading German medical societies and organizations
• Sample-Treatment with the Virucidal β-Propiolactone Does Not Preclude Analysis by Large Panel Affinity Proteomics, Including the Discovery of Biomarker Candidates
• SARS-CoV-2 variants, its recombinants and epigenomic exploitation of host defenses
• Selective replication and vertical transmission of Ebola virus in experimentally infected Angolan free-tailed bats
• Serological evidence of virus infection in <em>Eidolon helvum</em> fruit bats: implications for bushmeat consumption in Nigeria
• Serological evidence of zoonotic filovirus exposure among bushmeat hunters in Guinea
• Severe zoonotic viruses carried by different species of bats and their regional distribution
• Structural and Dynamical Basis of VP35-RBD Inhibition by Marine Fungi Compounds to Combat Marburg Virus Infection
• Summary of WHO infection prevention and control guideline for Ebola and Marburg disease: a call for evidence based practice
• T-bet⁺ B cells are activated by and control endogenous retroviruses through TLR-dependent mechanisms
• The Current Pathogenicity and Potential Risk Evaluation of Marburg Virus to Cause Mysterious "Disease X"-An Update on Recent Evidences
• The Importance of Networks and Relationships: Leveraging the Biocontainment Unit Leadership Workgroup for Special Pathogen Outbreak Response
• The mortality, modes of infection, diagnostic tests, and treatments of Marburg virus disease: A systematic review
• The neglected continuously emerging Marburg virus disease in Africa: A global public health threat
• Thermostable bivalent filovirus vaccine protects against severe and lethal Sudan ebolavirus and marburgvirus infection
• TMPRSS2-mediated SARS-CoV-2 uptake boosts innate immune activation, enhances cytopathology, and drives convergent virus evolution
• Transcriptional profiling of immune responses in NHPs after low-dose, VSV-based vaccination against Marburg virus
• Transcriptomics of Marburg virus-infected primary proximal tubular cells reveals negative correlation of immune response and energy metabolism
• Update on the Phylodynamic and Genetic Variability of Marburg Virus
• Use of in silico approaches, synthesis and profiling of Pan-filovirus GP-1,2 preprotein specific antibodies
• Vaccine Platform Comparison: Protective Efficacy against Lethal Marburg Virus Challenge in the Hamster Model
• Vertical transmission of SARS-CoV-2 - data from the German COVID-19 related obstetric and neonatal outcome study (CRONOS)
• WSV2023 - The second meeting of the world society for virology: One health - One world - One virology